PALB2 and breast cancer: All P/LP variants in the PALB2 gene were truncating variants and occurred more frequently in the group of patients with BC compared to controls, with an OR =3.0 [95% CI: 0.4–26.1]; however, the difference was not statistically significant (p > 0.05).